Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Clinical trial NCT00910910 · COMPLETED

Trial details

NCT number: NCT00910910
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia

Start date: 2009-10-13
Primary completion: 2014-03-31
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.